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FREQUENT BACK PAIN AND SUBSEQUENT MORTALITY 
AMONG OLDER COMMUNITY-DWELLING WHITE WOMEN 
IN THE STUDY OF OSTEOPOROTIC FRACTURES (SOF) 
ERIC J. ROSEEN 
ABSTRACT 
 Introduction: While the impact of back pain on morbidity in older adults is well-
understood, the influence of back pain on mortality is unclear. Back pain is the leading 
cause of disability worldwide, and disability is associated with elevated risk of mortality. 
Thus, we hypothesized that older women with persistent back pain would have a higher 
risk of mortality over 16-years of follow-up, compared to those with no back pain among 
participants in the Study of Osteoporotic Fractures (SOF), a large multisite cohort study. 
Furthermore, we hypothesized that limitations of Instrumental Activities of Daily Living 
(IADLs) would mediate a greater proportion of the mortality risk, compared to two 
objective measures of physical function, walking and chair stand speed. 
 Methods: The analytic sample included 8,321 SOF participants (mean age 71.5, 
SD=5.1) who answered back pain questions at baseline (1986–87) and visit 2 (1989–90). 
We created a four-category back pain variable by combining responses at two interviews 
(baseline and visit 2). Categories included: no back pain (24%), non-persistent back pain 
(23%), and infrequent (44%) or frequent (9%) persistent back pain. Participants were 
followed from visit 2 through visit 9 (2006–08). Death was confirmed with receipt of 
death certificates. Using Cox-proportional hazards, we calculated hazard ratios (HR) and 
95% confidence intervals (CI) for all-cause and cause-specific mortality with the ‘no 
		 vi 
back pain’ participants as our reference group. We adjusted for age, sociodemographic 
characteristics, self-reported general health, smoking status, comorbid conditions (e.g., 
prevalent vertebral fractures, osteoarthritis, hip pain, diabetes, hypertension), previous 
stroke, history of breast cancer, hospitalizations and falls in the previous year. We 
evaluated self-reported IADL limitations, slow walking speed, and slow chair stand time 
as a priori mediators of back pain and subsequent mortality.  
 Results: A total of 4975 women (55.8%) died over the follow-up period. A higher 
proportion of women with frequent persistent back pain died (65.8%) compared to those 
with no back pain (53.5%) (adjusted HR = 1.24; 95% CI 1.11 to 1.39).  We observed an 
increase in cardiovascular (adjusted HR = 1.34; 95% CI 1.12 to 1.62) and cancer 
(adjusted HR = 1.33; 95% CI 1.03 to 1.71) mortality. No increased risk was observed for 
other back pain groups. A larger proportion of the association was mediated by IADL 
limitations (47%), compared to poor performance on chair stand (27%) and walking 
speed (24%).  
 Conclusion: Compared to older women with no back pain, those with frequent 
persistent back pain had an increased risk of mortality, which underscores the importance 
of developing safe interventions to address and prevent this condition. Therapies that 
address IADL limitations or improve physical function (e.g. walking speed, chair stand) 
may be ideal for preventing early death in individuals with back pain. 
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Introduction 
 Back pain is the leading cause of disability worldwide (Vos 2015). In a systematic 
review of the prevalence of back pain in adults, the point prevalence and 1-month 
prevalence were estimated to be 11.9% and 23.2%, respectively (Hoy 2012). This review 
also found that women and those aged 40–80 years had the highest prevalence of back 
pain. Women report more frequent and severe back pain than men (Merrill 1997, 
Fillingim 2009). Among older community dwelling adults interviewed monthly over 10 
years, women were more likely than men to experience restrictive back pain, i.e., 37.5 vs. 
24.4 reports of restrictive back pain per 1,000 person-months (Makris 2011). While the 
relationship between back pain and morbidity in older adults is well established (Patel 
2013, Di Iorio 2007), the impact of back pain on mortality is relatively unknown. In a 
large sample of community-dwelling older women we assessed the risk of mortality over 
16-years of follow-up. Additionally, we evaluated whether this association was mediated 
by self-reported and performance-based measures of functioning. 
 To our knowledge, only eight studies have evaluated the relationship between back 
pain and mortality (Astrand 1987, Penttinen 1994, Heliovaara 1995, Torrance 2010, 
Kareholt 1998, Fernandez 2017, Zhu 2012, Docking 2014). While no association of 
back pain and mortality was observed in adult laborers with 13–23 years of follow-up, 
these studies included younger adults and may be biased by the healthy worker effect 
(Astrand 1987, Penttinen 1994, Heliovaara 1995). Among community-dwelling older 
adults followed for 10 years (Torrance 2010) to 20 years (Kareholt 1998), those with 
general chronic pain had an increased risk of mortality; however, adults with back pain in 
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particular had no increase in mortality risk. Among older twins, back pain was associated 
with a small increase in risk of mortality; this finding was attenuated after adjusting for 
physical functioning (Fernandez 2017). However, treating poor physical function as 
confounders rather than a mediator may underestimate the effect of back pain on 
mortality. While it is ideal to differentiate back-specific or other disability accrued over 
the life course, this is particularly challenging for older adults who may have multiple 
conditions contributing to disability (e.g., back pain, hip and knee osteoarthritis). Our 
study measured other potential causes of disability (prevalent vertebral fractures using 
morphology, hip and knee osteoarthritis using self-report), helping us to improve 
estimates of the association of back pain and mortality.  
 Definitions of back pain used in studies of subsequent mortality often used a single 
question to define back pain, failing to distinguish severity of back pain (e.g. frequency, 
intensity). While back pain in general is common, the impact of back pain on disability or 
general health varies substantially and older adults with only minor or infrequent 
symptoms may not have an elevated risk of mortality. In studies that used a more 
restrictive definition of back pain, older women with more severe back pain had a greater 
risk of mortality over 5- and 20-years of follow-up, than those without back pain. These 
studies assessed back pain experienced daily (Zhu 2012) or back pain and self-reported 
disability (Docking 2014). However, these studies only assessed back pain at one time 
point. Including participants whose back pain may have subsequently improved may have 
underestimated these associations. Through characterizing back pain by its frequency and 
whether or not it persisted over a two-year period, our study has allowed us to explore the 
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potential effects of back pain subgroups on subsequent mortality.   
 To our knowledge, no previous study has prospectively evaluated potential mediators 
on the causal pathway from persistent back pain to death. Back pain is associated with 
functional decline in older adults; elderly individuals with back pain have more 
limitations of instrumental activities of daily living (IADLs), and perform poorly on 
objective measures of physical function than those without back pain (Di Iorio 2007). 
Using disability concepts from the International Classification of Functioning, Disability, 
and Health (ICF) framework of the World Health Organization, back pain may limit 
physical activity, impair physical performance (e.g., walking speed, chair stand), and 
restricted participation in social roles such as IADLs, work, recreation, or self-care 
(WHO ICF 2002, Jette 2009). Extending beyond the ICF disability framework, back 
pain may influence mortality, i.e. back pain that leads to IADL limitations may also result 
in earlier death. Impaired mobility may similarly mediate the association between back 
pain and mortality. Indeed, poor performance on a physical performance battery (i.e., 
standing balance, gait speed, and chair stand) (Ensrud 2015) or walking speed alone 
(Studenski 2011) are associated with early all-cause mortality in older adults. 
Furthermore, following impaired mobility and/or limited IADLs due to back pain, 
general health may decline leading to development or worsening of various comorbid 
conditions (e.g., obesity, hypertension, diabetes) associated with cardiovascular death. 
There is a need to clarify the causal pathway from back pain to all-cause and disease 
specific mortality.  
 In previous analyses of the Study of Osteoporotic Fractures (SOF), we found that 
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older women with more frequent back pain at baseline and first follow-up visit were 34% 
more likely to die over an 8-year follow-up period than women with no back pain 
(adjusted OR =1.34; 95% CI 1.10 to 1.64). However, these results were based on logistic 
regression models and may be biased as follow-up time is fixed at 8-years for all 
individuals, despite date of death. For the current study, we use Cox proportional hazards 
models to incorporate information gained by censoring to improve estimates of the 
association of back pain and mortality over time. Furthermore, we examined both all-
cause and cause-specific mortality, and extended the follow up period to 16 years. 
Additionally, we have prospectively investigated whether self-reported IADL limitations 
or poor performance on physical function measures (e.g., walking speed, chair stand) 
mediate the relationship between frequent back pain and mortality. We tested the 
following hypotheses: 1) compared to older women without back pain, those with 
frequent back pain over two years will have an increased mortality risk over the 
following 16 years; and 2) self-reported IADL limitations will explain (i.e., mediate) a 
larger amount of the association between persistent back pain and mortality compared to 
the amount that is mediated by performance-based physical function. 
  
Methods  
Study population 
 The Study of Osteoporotic Fractures (SOF) is an ongoing prospective cohort study of 
9,704 community-dwelling white women 65 years or older. SOF study methods are 
described briefly below (Figure 1) and in detail elsewhere (Cummings 1990). 
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Participants were enrolled between September 1986 and October 1988 from four US-
based geographic regions (Baltimore, MD, Minneapolis, MN; Monongahela Valley, PA; 
and Portland, OR). Women who were unable to walk independently or who had bilateral 
hip replacements were excluded. Data were collected during clinical interviews and 
physical examinations at baseline and approximately every two years afterwards. 
Institutional Review Board approval was obtained at each SOF clinical center’s 
Institutional Review Board for original data collection. This sub-study, a secondary 
analysis of back pain and mortality, was approved by the Boston University Medical 
Campus Institutional Review Board.  
 
Analytic Sample 
 We performed a secondary analysis of the original SOF cohort. We first identified 
participants (n=8915) with self-report information on back pain at baseline (V1), which 
took place in 1986 and 1987, and their first follow up visit (V2), which took place in 
1989 and 1990. Our complete case analysis also required complete collection of 
information for covariables used in multivariable models (n=8321). Variables for 
mediation analyses came from the V3 interview (1991); therefore participants who died 
before completing this interview were excluded from the mediation analyses. 
Additionally, Inclusion into our three mediation analyses required complete data at V3 on 
IADLs (n=7936), or chair stand (n=6797), or walking speed (n=6913).  
 
 
		
	 6 
Back Pain Measures 
 We created a 4-category back pain variable to identify participants with 1) no back 
pain; 2) non-persistent back pain; 3) infrequent back pain or 4) frequent back pain at 
visits 1 and 2.  At V1 and V2, patients were asked, “Have you experienced back pain in 
the past 12 months?” and (if yes), “How often do you experience back pain?” Participants 
reporting back pain symptoms ‘most of the time’ or ‘constantly’ at both time points were 
classified as having ‘frequent’ back pain. Participants with back pain on both visits, who 
reported less frequent back pain (i.e., ‘some of the time’ or ‘infrequently)’ on at least one 
visit were classified as having ‘Infrequent’ back pain. Back pain reported at only one of 
two time points (i.e., V1 or V2) was characterized as ‘non-persistent’ back pain. 
 This variable was examined for consistency with other SOF measures of back-pain at 
a single time point, V2 (Appendix 1). We evaluated similarities between our measure and 
self-report of back pain intensity (severe, moderate, mild), number of back pain sites (1, 
2, or 3 regions), if back pain interfered with activities of daily living, and inability to lift 
10 pounds (yes/no) in general or due to back pain. Additionally, we evaluated differences 
between groups in reported age of first back pain episode ever.  
 
Vital Status 
 All-cause and disease-specific mortality was determined from V2 to until V9 (2006–
08). In addition to comprehensive clinical visits approximately every 2 years, participants 
were contacted by mail or telephone every 4 months to assess outcomes, including vital 
status, and confirm home address. Follow-up for vital statistics were 100% complete at 
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16 years of follow up at V9. All deaths were confirmed by receipt of death certificates.  
 
Mediator Variables  
Instrumental Activities of Daily Living (IADLs) 
 Participants self-reported their ability to perform each of 5 IADLs at each SOF visit. 
Participants indicated if they had any difficulty (yes/no/doesn’t do) with each of the 
following IADL tasks: 1) Walking 2–3 blocks; 2) Climbing up 10 steps; 3) Preparing a 
meal; 4) Performing heavy housework; and 5) Shopping for groceries or clothes. We 
summed the total number of activities each participant reported being unable to do 
(possible range 0–5) at V3 and subsequently dichotomized it to define ‘IADL limitations’ 
as no limitations (0) versus unable to do 1 or more of these activities (1). 
 
Physical Function 
 We measured two aspects of physical function: chair stand speed and walking speed. 
Participants were classified as ‘poor’ or ‘normal’ on each performance test using cut 
points from a similar study of a slightly older population (Cesari 2005, Cesari 2009). For 
the chair stand speed, we timed how long it took participants to stand from a seated 
position five times without using their arms (Ensrud 1994). Participants were 
characterized as having poor performance if they were unable to perform, used arms for 
assistance, or took longer than 17 seconds to perform five chair stands; otherwise they 
were classified as having “normal” performance (Cesari 2005, Cesari 2009). For 
walking speed (meters/second), we took the average of two trials of walking a 6-meter 
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course at usual pace (Ensrud 1994). Poor performance was defined as slower than 1.0 
meters per second (Cesari 2005, Cesari 2009).  
 
Covariates 
 All covariates were obtained from visit 2 when available, since this was the most 
recent assessment of back pain; we indicate which covariates were available only at V1. 
Sociodemographic variables included age at V2 (continuous variable calculated by 
subtracting date of birth from enrollment date), high school education at V1 (yes or no), 
currently married at V1 (yes or no; options included married, widow, separated, divorced, 
or never married), and living alone (“Do you live alone?” yes or no). We used 
recruitment site as a proxy for residence in one of the following four geographic areas 
(Baltimore, MD; Minneapolis, MN; Pittsburgh, PA; Portland, OR).  
 Health variables included body mass index (BMI, calculated as weight in kg divided 
by height in meters squared), and obese participants were identified (yes or no, if BMI > 
30.0 kg/m2). We identified current or previous smoking (yes or no) at baseline. General 
health was assessed, “How do you think your health is compared to others your age?” 
with response options being excellent, good, fair, poor, and very poor; responses were 
dichotomized as ‘excellent’ or ‘not-excellent’ general health. Prevalent vertebral fractures 
(yes or no) was identified at V1 on imaging using morphometry (Kado 1999). Hip pain 
and arthritis were assessed separately: hip pain (“Have you ever had pain in or around 
either hip joint, including the buttock, groin, or either side of the upper thigh, on most 
days for at least one month?” yes or no); arthritis (“has a doctor ever told you that you 
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have you have arthritis?” yes or no). One or more falls in the past year (yes or no) was 
identified by self-report at V2. Any hospitalizations in previous year were also identified 
through self-report at V2 (yes or no). We assessed the following conditions and health 
events: diabetes (“had a doctor had ever told you that you have diabetes or ‘sugar’ 
diabetes?” yes or no), previous stroke (“Since V1 has a doctor told you that you had a 
stroke, a blood clot in the brain, or bleeding in the brain, or stroke?” yes or no); previous 
breast cancer at V1 (“Have you ever had breast cancer?” yes or no), and previous breast 
surgery (“Have you ever had surgery on your breasts?” yes or no). Blood pressure was 
measured at V1; ‘Hypertension’ was defined as a systolic blood pressure above 140 
mmHg and/or diastolic blood pressure above 90 mmHg. Participants were asked if they 
had used an anxiety medication over the previous year (yes or no).   
 
Statistical Analysis 
Descriptive Analyses 
 We compared baseline characteristics of women across the four back pain categories, 
using “no back pain” as the reference group. Chi-square tests were used for categorical 
variables and ANOVAs were used for continuous variables. Variables identified as 
clinically relevant to the association between back pain and mortality were included in 
our multivariable models.  
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Survival Analyses 
 Kaplan-Meier survival curves were used to plot survival according to back pain 
group. Participants contributed person-time starting at V2 through follow-up until death, 
termination from SOF, or censoring of participants at V9 (Allison 2010). We assessed 
differences between curves using the log rank test. We created additional curves for other 
measurements of back pain (e.g., severity, frequency) assessed at a single timepoint (V2).  
 We calculated mortality rates as number of deaths per 10,000 life years. We 
calculated hazards ratios (HR) and 95% confidence intervals (CI) of the association 
between each of the 3 back pain categories vs. no back pain on mortality using Cox 
proportional hazards regression models. A multivariable Cox proportional hazards model 
was developed to adjust for potential confounders. In model 1, we adjusted for 
sociodemographic co-variables. In model 2, we added health-related variables. We 
calculated power for survival analyses, for the associations between back pain and 
mortality across the 16-year follow-up period. We anticipated adequate (99%) power to 
detect a HR=1.5 for respondents with frequent back pain vs. no back pain at baseline 
based on a 2-sided alpha = 0.05 and a fixed sample of 8,902 participants, of whom 10% 
(n=834) had frequent back pain, and 23% (n=2112) have no back pain.  
 
Mediation Analyses 
 To examine whether the relationship between frequent back pain and mortality 
operated through a disability pathway we performed mediation analyses. We applied 
mediation methods (Vanderweele 2015, Valeri 2015) to calculate the direct and indirect 
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effects of back pain on mortality, and the proportion of effect mediated by each mediator 
variable, adjusted for potential confounders. Our initial 4-category back pain exposure 
was dichotomized to fit mediation macro and maximize statistical power. We compared 
participants with ‘frequent’ back pain to all other participants (i.e., ‘no back pain’, ‘non-
persistent’, and ‘Infrequent’ back pain groups were collapsed to form a single group). 
Direct and indirect effects of back pain on mortality, presented as odds ratios (OR) and 
95% CIs, were calculated using logistic regression. The proportion of the total effect 
explained by the presence of each individual potential mediator, or percent mediated, was 
computed as beta coefficient for the indirect effect divided by the beta coefficient for the 
total effect. 
 We chose this approach over standard approaches (i.e., difference method, product 
method) because it incorporates interaction between back pain and mediator variables 
(Baron 1986, Vanderweele 2015), which may lead to more accurate estimates of direct 
and indirect effects of back pain on mortality. This method assumes that the following 
four confounder-types have been measured and appropriately adjusted for in 
multivariable models: 1) exposure – outcome confounders; 2) exposure – mediator 
confounders; 3) mediator – outcome confounders; 4) mediator – outcome confounder 
cannot be affected by the exposure. Furthermore, addressing interaction and these four 
confounder-types is thought to improve estimates of direct and indirect effects of back 
pain on mortality. SAS version 9.4 (Cary, North Carolina) was used for all statistical 
analyses. 
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Results 
Sample 
 Of the original 9704 SOF participants, our analytic sample contained 8,915 
participants (Figure 1).  All were white and their mean age was 71.5 years (SD 5.1) at 
V2. Most participants reported back pain (76.3%), and 9.5% reported frequent back pain. 
While some sociodemographic characteristics were similar between back pain groups 
(e.g., age, marital status), participants with frequent back pain reported poorer general 
health, and were more likely to be obese, have a co-morbid musculoskeletal condition 
(e.g., prevalent vertebral fracture, osteoarthritis, hip pain) or other comorbidities (Table 
1). The 789 participants excluded from this study were similar to those included in the 
analytic sample in terms of education, marital status, and self-report of hip pain and 
osteoarthritis; however, women who were excluded had slightly more prevalent vertebral 
fractures at V1, and were less likely to report ‘excellent health’; no other clinically 
important differences were identified (Appendix Table 1). 
 
Association between back pain and survival 
 A total of 5426 participants (61%) died over the 16-year follow-up period. The 
median length of follow-up was 13.9-years (inter-quartile range, 8.9 to 18.2 years). A 
higher proportion of participants with frequent back pain died (72%) compared with 
those who reported no pain, non-persistent pain, or infrequent back pain (the proportion 
who died ranged from 58%–61%). Participants with frequent back pain reported more 
severe pain intensity, were more likely to be unable to lift 10 pounds, or restrict activity 
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due to back pain than other participants (Table 2).  Moreover, participants with frequent 
back pain reported an earlier mean age of onset (45 years) than those with infrequent 
back pain (53 years) or non-persistent back pain (61 years). All back pain measurements 
were significantly correlated, with correlation coefficients ranging from 0.21 to 0.88 
(Appendix Table 2).  
 Kaplan Maier curves show significant differences in survival for all-cause, 
cardiovascular, and cancer deaths (Figure 3). Compared with women with no back pain, 
those with frequent back pain were 44% more likely to die over the follow-up in age-
adjusted analyses (age-adjusted HR =1.46; 95% CI 1.32, 1.61) (Table 3).  This 
association was attenuated when adjusting for potential confounders (fully-adjusted HR = 
1.24, CI 1.11–1.39). Our findings show an elevated risk of cardiovascular (fully-adjusted 
HR = 1.34; 95% CI 1.12 to 1.61) and cancer (fully-adjusted HR = 1.33; 95% CI 1.03 to 
1.71) mortality. We observed no increased risk of mortality for the other back pain 
groups compared with no back pain. While additional back pain measurements also were 
associated with all-cause mortality, the presence of any back pain at V2 (yes or no) was 
not (fully-adjusted HR = 0.98, 95% CI 0.92, 1.05) (Appendix Table 3).  
 
Mediation 
 We compared participants with ‘frequent’ back pain (n=586 to 720) with those 
without frequent back pain (n=6211 to 7216) in our three mediation models (Figure 1). 
Missing data for three mediators was similar in our original back pain exposure 
(Appendix Figure 2). Baseline sample characteristics in each of three mediator analyses 
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were similar to complete case sample (Appendix Table 4). Estimates of the total effect 
of back pain on mortality varied slightly among our three mediator models, i.e., models 
that assessed IADL impairments (adjusted OR = 1.28, 95% CI 1.06 to 1.52), or slow 
chair stand (adjusted OR = 1.19, 95% CI 0.97 to 1.45), or slow walking speed (adjusted 
OR = 1.22, 95% CI 1.02 to 1.46) (Table 4). The indirect effect of back pain on mortality 
through IADL impairment (adjusted OR = 1.12, 95% CI 1.08 to 1.15) was larger than 
through slow chair stand (adjusted OR = 1.05, 95% CI 1.03 to 1.08) or walking (adjusted 
OR = 1.05, 95% CI 1.02 to 1.07) speed. Similarly, while nearly half (47%) of the 
mortality risk was mediated by IADL limitations, only a fourth of the overall effect was 
mediated by chair stand and walking speed (27% and 24%, respectively).  
 
Discussion 
 In this sample of community-dwelling older women followed for 16 years, those 
reporting frequent back pain had a 24% increase in risk of all-cause mortality compared 
to participants without back pain. Frequent back pain was also associated with elevated 
cancer and cardiovascular mortality. While a majority of participants (76.3%) reported 
back pain at baseline (either V1 or V2 exams), most experienced non-persistent (23.1%) 
or infrequent (43.7%) back pain which was not associated with a higher all-cause or 
disease specific mortality compared to those without back pain. Additionally, results 
suggest limited ability to perform 1 or more IADLs was a strong mediator of this 
association, while slow chair stand and gait speed mediated less of this association. These 
findings support our hypothesis that more frequent back pain that persists over two years 
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is associated with subsequent mortality, and that this association is in part mediated by 
IADL limitations and performance-based physical function impairments. 
 Our findings for those with frequent back pain were similar to prior studies evaluating 
daily back pain and disabling back pain, which found an elevated mortality risk in older 
women (Zhu 2007, Docking 2014). We also observed that back pain as a dichotomous 
exposure (yes or no) at a single visit (V2) was not associated with an increase in 
mortality. This too is consistent with previous studies (Astrand 1987, Penttinen 1994, 
Heliovaara 1995, Torrance 2010, Kareholt 1998). Subgrouping back pain participants 
(e.g., by frequency or impact on physical function) emerged as an essential aspect of 
understanding the relationship between back pain mortality. Our findings are aligned with 
studies of other musculoskeletal condition; hyperkyphosis (Kado 2004, Kado 2007) and 
lower extremity osteoarthritis also carry an elevated risk of mortality (Neusch 2011, 
Barbour 2015).  
 We also observed an elevated risk of cardiovascular mortality. While this is 
consistent with one previous study, (Zhu 2007) it is inconsistent with most others 
(Penttinen 1994, Heliovaara 1995, Torrance 2010, Fernandez 2017). This is the first 
study to evaluate cancer-specific mortality among older adults with back pain. 
Participants were evaluated for current or previous cancer at baseline, including lumbar 
x-rays taken on baseline visit. Thus, it is unlikely that patients had back pain from spinal 
metastases at baseline. Similar higher rates of cancer-specific mortality have been 
observed in older adults with chronic pain (Torrance 2010, Smith 2014) and 
osteoarthritis (Neusch 2011).  
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 Our study is the first to assess mediation of the association of back pain in mortality. 
However, two previous papers noted substantial attenuation of their hazard ratio 
estimates after adjusting for physical activity (Zhu 2007) and performance based 
physical function (Fernandez 2017) measures, which may suggest mediation (Baron 
1986). Elevated mortality risk in osteoarthritis is thought to be mediated by disability 
(Hoeven 2013). While our findings have explored a potential pathway from back pain to 
disability to death, alternative pathways may exist. 
 We have proposed that when back pain is persistent, it may lead to IADL limitations, 
and poor mobility, which may subsequently cause early death. This pathway is a logical 
extension of the WHO ICF disability framework, i.e. back pain that leads to disability, 
may also lead to an earlier death. Furthermore, it is supported by two large bodies of 
literature: 1) back pain is the leading cause of disability worldwide (Vos 2016), 
particularly in older women (Weiner 2003, Scudds 1997, Edmond 2003); and 2) 
disability in older adults leads to death (Cooper 2014, Feeny 2012, Guralnik 1995). 
This pathway may also involve back pain causing weight gain, poorer general health, 
development of comorbid conditions, and ultimately cardiovascular death. However, in 
each of our mediation analyses of physical function-related measures we observed a 
residual direct effect, which suggests alternative causal pathways from back pain to 
mortality exist. While back pain may directly limit physical function, older adults may 
inappropriately avoid physical activities, including IADLs, due to fear of re-injury or 
worsening of symptoms. Back pain impacts mental health, and mental health conditions 
(e.g., anxiety and depression) may subsequently lead to earlier mortality. Lastly, 
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degenerative changes of the spine, which are common in older adults, may lead to back 
pain and elevated levels of inflammatory cytokines (Johnson 2015, Dudli 2016). This 
inflammation may lead to subsequent cancer and cardiovascular death (Couzin-Frankel 
2010).  
 To our knowledge, this study is the first to define back pain at multiple time points 
when assessing risk of mortality. Symptoms that truly persists over time may have a 
greater impact on risk of disability and death. Defining persistent back pain as symptoms 
reported at two separate time points likely reduced misclassification bias of back pain 
cases. Roughly 7% of participants reported ‘frequent’ symptoms at baseline and 
‘infrequent’ or no back pain two years later. This approach differentiated which subsets 
of participants with back pain were at higher mortality risk. However, our measure was 
highly correlated with back pain measurements from a single time point which observed 
similar mortality risk. Furthermore, our results were corroborated by finding higher 
mortality risk among participants with greater back pain frequency and more back-
specific disability in our sample, as well as previous studies of daily (Torrance 2010) or 
disabling (Zhu 2007) back pain.  
 Our study had several limitations. We may have introduced selection bias when 
restricting our analytic sample (for survival analyses) to participants alive at V2 with 
complete data on back pain exposure and key covariables. Selection bias may be of 
greatest concern in mediation analysis, due to further restriction of analytic sample, i.e., 
requiring data on V3 mediators. The proportion of missing data was similar across our 4 
back-pain exposure levels and baseline sample characteristics remain similar across all 
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analyses. However, slightly more missing data in ‘frequent’ back pain group may have 
biased our results towards the null. We were unable to follow participants immediately 
after the onset of back pain. Our study only included white women and may not be 
generalizable to men or other races/ethnicities. For example, women are more likely to 
report more intense, frequent, or restrictive pain than men (Merril 1997, Fillingim 2009). 
Black and Hispanic patients report worse pain, poorer physical function, and receive 
fewer intensive diagnostic and treatment approaches compared to white patients (Carey 
2004, Carey 2010). Additionally, our participants were healthy community dwelling 
older adults and may not be representative of the general population. For older persons 
who are already disabled or living in a nursing home, back pain may have a greater 
impact on back-related morbidity and mortality; such patients were excluded from 
enrolling in SOF. While we will be able to adjust for many potential confounders we 
were unable to adjust for depression in the complete case analysis due to substantial 
residual missing data (n=1300), and a number of our potential confounders (e.g. 
osteoarthritis) were self-report. However, we were able adjust for anxiety medication use 
and self-report general health, which may be helpful proxies of mental health. We may be 
able to adjust for depression in future analyses using multiple imputation. Additionally, 
some comorbid conditions may be both confounders and mediators in the relationship 
between back pain and mortality. For example, while obesity is a known risk factor for 
back pain, reduced activity related to chronic low back pain may lead to weight gain, 
obesity, and earlier death. Thus, we may be biasing the true relationship of back pain and 
mortality towards the null in our multivariable models.  
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 We only assessed mediators at one time point, this may bias our results to the null. 
We were unable to assess all potential mediators of the back pain relationship. For 
example, a range of psychological symptoms are associated with back pain including 
depression, anxiety, and low self-efficacy. Self-reported inability to perform IADLs may 
capture physical disability and psychosocial factors contributing to condition. 
Furthermore, we observed the effect of one potential mediator at a time. Future studies 
should examine interaction between these mediators, e.g., between disability and 
psychosocial factors. 
 Nonetheless, our study had several strengths. The Study of Osteoporotic Fractures is a 
very large cohort study with over 20 years of follow-up. Participants were generally 
healthy at baseline, which may have limited confounding by other health conditions that 
impact mortality. The sample experienced minimal loss to follow-up in comparison to 
previous studies on this association. Additionally, 100% reporting on mortality and 
access to cause of death allowed us to report disease specific mortality risk. Lastly, our 
large homogeneous sample may have provided an accurate hazards ratio estimate for the 
risk of mortality in older white women with back pain; a population previously shown to 
have an elevated mortality risk (Zhu 2007, Torrance 2010).  
 The results of our mediation analyses suggest that disability is an important 
intermediate on the pathway from back pain to subsequent mortality. Future research 
should prospectively examine the longitudinal impact of disability over time following 
the onset of back pain. Clinicians should identify patients with back pain who experience 
frequent symptoms or report limited ability to perform daily activities. Frequent or 
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disabling back pain should be considered as a risk factor for early death. However, it 
remains unclear how musculoskeletal conditions contribute to death and alternative 
causal pathways should be considered in future research. Common musculoskeletal 
conditions should be considered as a potential contributor to mortality on death 
certificates, as is done in Australia, where 5% of deaths in 2013 were directly caused by, 
or contributed to by, musculoskeletal conditions (AIHW 2016). Lastly, our results 
suggest that it is important to manage back pain across the lifespan. Understanding the 
potential role of treatment and self-care to address disability across the life course and 
mitigate risk of mortality in older adults is of significant public health importance. 
Treatment should emphasize function, particularly the ability to perform IADLs. 
 
Conclusion  
 We found frequent and persistent back pain to be associated with subsequent 
mortality among older community-dwelling white women over 16-years of follow-up.  
The proportion of adults over the age of 65 is increasing rapidly in the U.S. and 
optimizing physical health and extending life for older adults is an important public 
health goal (9). These results could lay the foundation for future work that may further 
clarify the burden of back pain and its impact on aging, disability, and death. Clinicians 
should thoroughly evaluate and monitor older participants with frequent back pain. A 
deeper understanding of these potential outcomes may inform healthcare decision making 
for older adults experiencing back pain. 
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Figure 1. Study flow diagram 
* Complete case analysis required complete data on key covariates used in multi-variate modeling, including: age at V2, high school 
education at V1 (yes or no), currently married at V1 (yes or no), living alone at V1 (yes or no), recruitment site, obese at V1 (yes or no), 
current smoker at V2 (yes or no), excellent health at V1 (yes or no), prevalent vertebral fractures on V1 x-ray (yes or no), hip pain at V2 
(yes or no), arthritis at V1 (yes /no), falls in past year at V2 ( >1 fall or none), hospitalizations in past year at V2 ( >1 hospitalization or 
none), diabetes at V1 (yes or no), hypertension at V1 (yes or no), previous stroke (yes or no), history of breast cancer at V1 (yes or no), 
previous breast surgery at V2 (yes or no), and use of anxiety medication in previous year at V2 (yes or no). ** mediation for IADL 
impairments at V3 (n=7936) ***mediation for slow chair stand at V3 (n=6797) **** mediation for slow walking speed at V3 (n=6913)
Recruitment Sites
Portland, OR 
Kaiser Permanente health plan members
Minneapolis, MN 
Group Health Incorporated plan members
Patient lists from previous studies 
Jury-selection lists in Hennepin County
Monongahela Valley, PA 
Voter registration lists
Baltimore, MD 
List of individuals with drivers license and 
identification cards in Baltimore county
Inclusion Criteria:
Women 65 or older recruited at one of the  
four above geographic sites from 
September 1986 to October 1988
Exclusion Criteria: 
1) Black women and men because of the 
low expected incidence of hip fractures 
2) Women unable to walk without the 
assistance of another person
3) Women with bilateral hip replacements
3897 (43.7%)
Infrequent Back Pain
3622 (43.5%)  
275 missing covariates* 
2059 (23.1%)
Non-Persistent Back Pain
1919 (23.1%)  
140 missing covariates* 
2112 (23.7%)
No Back Pain
2001 (24.0%)  
111 missing covariates* 
586 (8.6%)*** 
159 Missing V3 chair stand
8321 in Complete Case Analysis
600 (8.7%)****  
145 Missing V3 gait speed
171 Died From
V2 and V3
34 Died from
V2 and V3
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Figure 2. Data collected on exposure (back pain), mediators (morbidity) and outcome 
(mortality) 
  
V1 
 
V2 
 
V3 
 
V4 
 
V5 
 
V6 
 
V8 
 
V9 
 
Baseline:  
Back pain measurement  
and baseline covariates 
x x       
  
Mediators 
(e.g., IADL limitations, 
performance-based  
physical function) 
  x      
 
 
Mortality (V2–V9) 
  x* x x x x x 
Baseline (V1) 1986–87; Visit 2 (V2) 1989–90; Visit 3 (V3) 1991; Visit 4 (V4) 1992–94; Visit 5 (V5) 
1995–96; Visit 6 (V6) 1997–98; Visit 7 (V7) 1999; Visit 8 (V8) 2002–2004; Visit 9 (V9) 2006–08 
* Mediation analysis excludes individuals who died between v2 and v3 
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Figure 3.0. Kaplan Meier Curves, All-Cause Mortality 
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Figure 3.1. Kaplan Meier Curves, Cardiovascular Mortality  
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Figure 3.2. Kaplan Meier Curves, Cancer Mortality 
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Figure 3.3. Kaplan Meier Curves, Pulmonary Mortality 
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Figure 3.4. Kaplan Meier Curves, Cognitive Mortality 
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Table 1. Characteristics of women included in by back pain exposure status defined by 
combining self-report of back pain presence and frequency at baseline (1986–1988) and 
visit 2 (1988–1990) among 8321 SOF participants (complete case analysis) 
 No Back Pain 
Non- 
Persistent 
 
Persistent Back Pain 
   Infrequent Frequent 
 
Variables  
2001  
(24.0) 
1919  
(23.1) 
3622  
(43.5) 
779  
(9.4) 
 
Socio-demographic  
    
 
   Age at V2, y, mean (SD) 
73.3  
(5.1) 
73.4  
(5.0) 
73.5  
(5.0) 
73.7  
(5.1) 
 
   Education at V1, > 12 yrs, % 
764  
(38.2) 
757  
(39.5) 
1429  
(39.5) 
222  
(28.5) 
 
   Married at V1, % 
965  
(48.2) 
963  
(50.2) 
1865  
(51.5) 
380  
(48.8) 
 
   Lives alone at V1, yes, % 
855  
(42.7) 
772  
(40.2) 
1445  
(39.9) 
331  
(42.5) 
 
   Recruitment site at V1     
 
     Clinic A, % 
492  
(24.6) 
499  
(26.0) 
957  
(26.4) 
177  
(22.7) 
 
     Clinic B, % 
469  
(23.4) 
482  
(25.1) 
936 
(25.8) 
216 
(27.7) 
 
     Clinic C, % 
473  
(23.6) 
483  
(25.2) 
482  
(25.1) 
159 
(20.4) 
 
     Clinic D, % 
567  
(28.3) 
455  
(23.7) 
469  
(23.4) 
227  
(29.1) 
 
Health-related characteristics     
 
   General health at V1, excellent, % 
868  
(43.4) 
714  
(37.2) 
981  
(27.1) 
102  
(13.1) 
 
   Current smoker at V2, % 
157  
(7.9) 
141  
(7.4) 
279  
(7.7) 
81  
(10.4) 
 
   BMI at V1, kg/m2, mean (SD) 
26.1  
(4.3) 
26.2  
(4.3) 
26.6  
(4.5) 
27.2  
(5.0) 
 
   Obese at V1, BMI >30.0, % 
343  
(17.1) 
321  
(16.7) 
778  
(21.5) 
199  
(25.6) 
 
   Exercise (V1), 1 day / week, %* 
1573  
(78.6) 
1499  
(78.1) 
2843  
(78.5) 
554  
(71.2) 
 
Comorbid conditions     
 
   Prevalent vertebral fracture at V1, % 
304  
(15.2) 
348  
(18.1) 
767  
(21.2) 
214  
(27.5) 
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   Arthritis at V1, % 
892  
(44.6) 
1081  
(56.3) 
2591  
(71.5) 
666  
(85.5) 
 
   Hip pain at V2, % 
242  
(12.1) 
437  
(22.8) 
1365  
(37.7) 
515  
(66.1) 
 
   Fall in last year at V2, %  
465  
(23.2) 
546  
(28.5) 
1166  
(32.2) 
280  
(35.9) 
 
   Hospitalized in last year at V2, % 
230  
(11.5) 
264  
(13.8) 
555  
(15.3) 
186  
(23.9) 
 
   Depression, GDS > 6 at V2, %** 
39  
(2.3) 
53  
(3.3) 
145  
(4.7) 
76  
(11.8) 
 
   Hypertension calculated at V1, % 
735  
(36.7) 
720  
(37.5) 
1344  
(37.1) 
344  
(44.2) 
 
   Previous stroke at V2, % 
41 
(2.1) 
52  
(2.7) 
113  
(3.1) 
41  
(5.3) 
 
   Diabetes at V1, % 
119  
(6.0) 
120  
(6.3) 
251  
(6.9) 
67  
(8.6) 
 
   Breast cancer at V1, % 
87  
(4.4) 
115  
(6.0) 
189  
(5.2) 
38  
(4.9) 
 
   Breast surgery at V2, % 
445  
(22.2) 
449  
(23.4) 
1034  
(28.6) 
208  
(26.7) 
 
Medication Utilization     
 
   Advil use in past yr (v2), > 1 /wk, %*** 
349  
(17.5) 
401  
(21.0) 
1149  
(31.8) 
358  
(46.3) 
 
   Aspirin use in past yr (V2), >1 /wk, %^ 
652  
(32.6) 
678  
(35.4) 
1537  
(42.5) 
363  
(46.7) 
 
   Tylenol use in past yr (V2), > 1 /wk, %^ 
261  
(13.1) 
376  
(19.6) 
1011  
(28.0) 
313  
(40.2) 
 
   Anxiety medication use (V2), any, %  
149  
(7.4) 
207  
(10.8) 
577  
(15.9) 
182  
(23.4) 
 
Deaths after 8 years of follow-up 
383  
(19.1) 
376  
(19.6) 
691  
(19.1) 
226  
(29.0) 
 
Deaths after 16 years of follow-up 
1059  
(52.9) 
1043  
(54.4) 
1982  
(54.7) 
506  
(65.0) 
 
GDS, Geriatric Depression Scale; *Exercise information missing for 2 participants; **Depression 
information missing for 1300 participants; *** Advil information missing from 28 participants; 
^Tylenol and aspirin information missing from 15 participants 
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Table 2. Comparison of four-category back pain measurement developed by using 
questions from two time points, baseline (1986–1988) and visit 2 (1988–1990), to 
individual back pain questions from a single time point, visit 2, among 8915 SOF 
participants 
 
 
 
 
Back Pain Measurement 
 
No  
Back Pain 
 
Non-
Persistent 
 
 
 
Persistent Back Pain 
 
Infrequent 
 
Frequent 
 2112 (23.7) 2059 (23.1) 3897 (43.7) 834 (9.5) 
Additional back pain measurements     
    
Any back pain in past 12 mo, % 
 
0 (0) 
 
714 (34.7) 
 
3897 (100) 
 
834 (100) 
   Constant back pain over past year, % 0 (0.0) 20 (1) 85 (2.2) 267 (31.5) 
   Back pain limits activities, % 3 (0.1) 123 (6.0) 784 (20.2) 417(49.6) 
   Severe intensity, % 161 (7.6) 276 (13.4) 1223 (31.4) 551 (65.1) 
   Full spine pain, % 0 (0.0) 7(0.3) 148 (3.8) 115 (13.6) 
   Difficulty lifting 10 pounds, % 161 (7.6) 276 (13.4) 1223 (31.4) 551 (65.1) 
   Unable to lift 10 pounds due to back, % 4 (0.19) 35 (0.39) 183 (4.7) 122(14.5) 
   Age of onset, y, mean (SD) n/a 60.9 (18.0) 52.7 (19.5) 45.2 (20.4) 
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Table 3. Hazards ratios for participants with back pain, compared to participants with 
no back pain, and subsequent all-cause mortality from 1986–2008 among 8321 SOF 
participants, adjusted for potential confounders 
 
All-Cause Mortality 
Death 
Rate* 
Age-Adjusted 
HR  (95% CI) 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
  No Back Pain  
  (n=2001) 
 
428 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain  
  (n=1919) 
 
 
444 
 
1.05  
(0.96, 1.14) 
 
1.05  
(0.97, 1.14) 
 
1.01  
(0.93, 1.10) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
449 
 
1.04  
(0.97, 1.12) 
 
1.04  
(0.97, 1.12) 
 
0.98  
(0.91, 1.05) 
 
  Frequent Back Pain  
  (n=779) 
 
 
589 
 
1.46  
(1.32, 1.61) 
 
1.42  
(1.28, 1.57) 
 
1.24 
(1.11, 1.39) 
Cardiovascular Mortality     
  No Back Pain  
  (n=2001) 
 
150 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain 
  (n=1919) 
 
 
156 
 
1.05  
(0.92, 1.21) 
 
1.07 
(0.93, 1.23) 
 
1.02  
(0.89, 1.17) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
160 
 
1.06  
(0.94, 1.20) 
 
1.08  
(0.96, 1.22) 
 
1.01  
(0.89, 1.14) 
 
  Frequent Back Pain  
  (n=779) 
 
 
230 
 
1.62  
(1.37, 1.91) 
 
1.57  
(1.33, 1.85) 
 
1.34  
(1.12, 1.61)  
Cancer Mortality     
  No Back Pain  
  (n=2001) 
 
80 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain  
  (n=1919) 
 
 
84 
 
1.05  
(0.87, 1.27) 
 
1.05  
(0.87, 1.27) 
 
1.02  
(0.84, 1.24) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
86 
 
1.08  
(0.92, 1.27) 
 
1.08  
(0.92, 1.27) 
 
1.03  
(0.87,1.23) 
 
  Frequent Back Pain  
  (n=779) 
 
 
113 
 
1.44  
(1.14, 1.82) 
 
1.44  
(1.14, 1.82) 
 
1.33  
(1.03, 1.71)  
Breast Cancer Mortality     
  No Back Pain  
  (n=2001) 
 
34 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain  
  (n=1919) 
 
 
43 
 
1.31  
(1.00, 1.73) 
 
1.32  
(1.00, 1.74) 
 
1.33  
(1.00, 1.75) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
43 
 
1.25  
(0.98, 1.60) 
 
1.27  
(0.99, 1.62) 
 
1.17  
(0.90,1.52) 
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  Frequent Back Pain  
(n=779) 
 
 
 
117 
 
1.35 
(0.92, 1.98) 
 
1.42 
(0.96, 2.08) 
 
1.23 
(0.82, 1.86)  
Pulmonary Mortality     
  No Back Pain  
  (n=2001) 
 
46 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain  
  (n=1919) 
 
 
50 
 
1.08 
(0.85, 1.39) 
 
1.09 
(0.85, 1.40) 
 
1.02  
(0.79, 1.31) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
46 
 
0.98 
(0.79, 1.22) 
 
1.00 
(0.80, 1.24) 
 
0.87 
(0.69, 1.10) 
 
  Frequent Back Pain  
  (n=779) 
 
 
71 
 
1.65 
(1.23, 2.23) 
 
1.71 
(1.27, 2.30) 
 
1.30 
(0.94, 1.80)  
Cognitive Mortality     
  No Back Pain  
  (n=2001) 
 
47 
 
Ref 
 
Ref 
 
Ref 
 
  Non-Persistent Back Pain  
  (n=1919) 
 
 
50 
 
1.10 
(0.86, 1.41) 
 
1.08 
(0.85, 1.38) 
 
1.07 
(0.83, 1.37) 
 
  Infrequent Back Pain  
  (n=3622) 
 
 
43 
 
0.92 
(0.74, 1.15) 
 
0.89 
(0.71, 1.11) 
 
0.89 
(0.70, 1.13) 
 
  Frequent Back Pain  
  (n=779) 
 
 
38 
 
0.92 
(0.64, 1.34) 
 
0.88 
(0.60, 1.27) 
 
0.86 
(0.58, 1.28)  
 
* Deaths per 10,000 person years 
Model 1 includes sociodemographic characteristics: age at V2, high school education at V1 (yes or 
no), currently married at V1 (yes or no), living alone at V1 (yes or no), recruitment site 
Model 2 includes sociodemographic + health characteristics:  obese at V1 (yes or no), current 
smoker at V2 (yes or no), excellent health at V1 (yes or no), prevalent vertebral fractures on V1 x-
ray (yes or no), hip pain at V2 (yes or no), arthritis at V1 (yes or no), falls in past year at V2 ( >1 
fall), hospitalizations in past year at V2 ( >1 hospitalization or none), diabetes at V1 (yes or no), 
hypertension at V1 (yes or no), previous stroke (yes or no), history of breast cancer at V1 (yes or 
no), previous breast surgery at V2 (yes or no), and use of anxiety medication in previous year at V2 
(yes or no) 
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Table 4. Mediation analysis between frequent back pain at V2 and all-cause mortality at 
V9 in 6913–7936 SOF participants, adjusted for potential confounders 
 
 
Mediator* 
 
Total Effect 
(OR, 95% CI) 
 
Indirect Effect 
(OR, 95% CI) 
 
Direct Effect 
(OR, 95% CI) 
 
Proportion 
Mediated, % 
 
Age-adjusted  
    
 
 
IADL limitations (n=7936) 
 
1.54 
(1.30, 1.79) 
 
1.24 
(1.19, 1.29) 
 
1.24 
(1.04, 1.49) 
 
 
55% 
 
Performance-based physical 
function 
    
    
  Slow chair stand speed 
(n=6797) 
1.51 
(1.24, 1.78) 
1.16 
(1.11, 1.23) 
1.30 
(1.07, 1.54) 
 
41% 
  
 
  Slow walking speed (n=6913) 
 
1.57 
(1.33, 1.84) 
 
1.06 
(1.05, 1.08) 
 
1.48 
(1.25, 1.73) 
 
 
17% 
 
Fully Adjusted**  
    
 
 
IADL limitations (n=7936) 
 
1.28 
(1.06, 1.52) 
 
1.12 
(1.08, 1.15) 
 
1.15 
(0.94, 1.36) 
 
 
47% 
 
Performance-based physical 
function 
    
    
  Slow chair stand speed 
(n=6797) 
1.19 
(0.97, 1.45) 
1.05 
(1.03, 1.08) 
1.14 
(0.93, 1.38) 
 
27% 
  
 
  Slow walking speed (n=6913) 
 
1.22 
(1.02, 1.46) 
 
1.05 
(1.02, 1.07) 
 
1.17 
(0.97, 1.40) 
 
 
24% 
 
IADL: instrumental activities of daily living 
* Information for mediator variables was obtained at V3 
** Fully-adjusted model, includes: age at V2, > high school education at V1 (yes or no), currently 
married at V1 (yes or no), living alone at V1 (yes or no), recruitment site, obese at V1 (yes or no), 
current smoker at V2 (yes or no), excellent health at V1 (yes or no), prevalent vertebral fractures on 
V1 x-ray (yes or no), hip pain at V2 (yes or no), arthritis at V1 (yes /no), falls in past year at V2 ( >1 
fall or none), hospitalizations in past year at V2 ( >1 hospitalization or none), diabetes at V1 (yes or 
no), hypertension at V1 (yes or no), previous stroke (yes or no), history of breast cancer at V1 (yes or 
no), previous breast surgery at V2 (yes or no), and use of anxiety medication in previous year at V2 
(yes or no) 
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APPENDIX 1: SUPPLEMENTARY FIGURES AND TABLES 
Appendix Figure 1. Directed Acyclic Graph 
 
Appendix Figure 2. Study flow diagram following 4-category back pain exposure 
 
Appendix Table 1. Baseline characteristics for excluded participants and analytic sample 
 
Appendix Table 2. Back pain variables at baseline, descriptive statistics and correlation 
 
Appendix Table 3. Back pain variables, Kaplan-Maier curves, and hazards ratios 
 
Appendix Table 4. Comparison of baseline characteristics for excluded participants in 
mediation analyses and among collapsed exposure variables.  
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Appendix Figure 1. Directed Acyclic Graph 
 
  
A   à D à Y
A	=	Back	Pain
D =	Disability	
Y	=	Mortality
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Appendix Figure 2. Study flow diagram following	4-category	back	pain	exposure
* Complete case analysis required complete data on key covariates used in multi-variate modeling, including: age at V2, high school 
education at V1 (yes or no), currently married at V1 (yes or no), living alone at V1 (yes or no), recruitment site, obese at V1 (yes or no), 
current smoker at V2 (yes or no), excellent health at V1 (yes or no), prevalent vertebral fractures on V1 x-ray (yes or no), hip pain at V2 
(yes or no), arthritis at V1 (yes /no), falls in past year at V2 ( >1 fall or none), hospitalizations in past year at V2 ( >1 hospitalization or 
none), diabetes at V1 (yes or no), hypertension at V1 (yes or no), previous stroke (yes or no), history of breast cancer at V1 (yes or no), 
previous breast surgery at V2 (yes or no), and use of anxiety medication in previous year at V2 (yes or no). ** mediation for IADL 
impairments at V3 (n=7936) ***mediation for slow chair stand at V3 (n=6797) **** mediation for slow walking speed at V3 (n=6913)
Recruitment Sites
Portland, OR 
Kaiser Permanente health plan members
Minneapolis, MN 
Group Health Incorporated plan members
Patient lists from previous studies 
Jury-selection lists in Hennepin County
Monongahela Valley, PA 
Voter registration lists
Baltimore, MD 
List of individuals with drivers license and 
identification cards in Baltimore county
Inclusion Criteria:
Women 65 or older recruited at one of the  
four above geographic sites from 
September 1986 to October 1988
Exclusion Criteria: 
1) Black women and men because of the 
low expected incidence of hip fractures 
2) Women unable to walk without the 
assistance of another person
3) Women with bilateral hip replacements
3897 (43.7%)
Infrequent Back Pain
3464 (43.6%)** 
67 missing V3 IADL
3622 (43.5%)  
275 missing covariates* 
2059 (23.1%)
Non-Persistent Back Pain
1841 (23.2%)**
38 Missing V3 IADL
1919 (23.1%)  
140 missing covariates* 
2112 (23.7%)
No Back Pain
1911 (24.1%)**
51 Missing V3 IADL 
2001 (24.0%)  
111 missing covariates* 
586 (8.6%)*** 
159 Missing V3 chair stand
2971 (43.7%)***  
560 Missing V3 chair stand
1583 (23.3%)*** 
296 Missing V3 chair stand
1657 (24.4%)***  
305 Missing V3 chair stand
3028 (43.8%)****  
503 Missing V3 gait speed
1608 (23.3%)****  
271 Missing V3 gait speed
1677 (24.3%)**** 
285 Missing V3 gait speed
8321 in Complete Case Analysis
600 (8.7%)****  
145 Missing V3 gait speed
40 Died From
V2 and V3
40 Died from
V2 and V3
91 Died from
V2 and V3
34 Died from
V2 to V3
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Appendix Table 1. Baseline characteristics for excluded participants and analytic sample 
 
  
Analytic Sample 
 
Excluded 
 
Total n of 9704, % 
 
8915 (92%) 
 
789 (8%) 
 
Socio-demographic  
  
   Age, y, mean (SD) 71.5 (5.1) 73.0 (6.0) 
   Participants Education, >12y, % 3373 (37.9%) 281 (35.8%) 
   Participants Education, years, mean (SD) 12.6 (2.8) 12.3 (2.8) 
   Husbands Education, years, mean (SD) 12.4 (3.2) 12.4 (3.3) 
   Recruitment Site   
     Clinic A 2304 (25.8%) 154 (19.5%) 
     Clinic B 2246 (25.2%) 175 (22.2%) 
     Clinic C 2073 (23.2%) 351 (44.5%) 
     Clinic D 2292 (25.7%) 109 (13.8%) 
   
Health-related characteristics   
   General health, excellent, % 2822 (31.6%) 203 (25.8%) 
   Body mass index, kg/m2, mean (SD) 26.4 (4.5) 26.1 (4.7) 
   Obese, BMI >30.0, % 1745 (19.7%) 141 (18.1%) 
   
Comorbid conditions   
   Prevalent vertebral fracture, % 1732 (19.7%) 183 (23.5%) 
   Osteoarthritis, % 5519 (63.1%) 491 (63.3%) 
   Hip pain, %    3166 (35.8%) 276 (35.3%) 
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Appendix Table 2. Back pain variables at baseline, descriptive statistics and 
correlation 
 
 V1OFT V2OFT v1Back v2back v2LIM V2PART V2BAD V2Lift v2liftc 
V1OFT 1         
V2OFT 0.51* 1        
V1BACK … 0.49* 1       
V2Back 0.30* 0.87* 0.5* 1      
V2LIM 0.26* 0.44* 0.21* 0.32* 1     
V2Part 0.31* 0.76* 0.44* 0.81* 0.35* 1    
V2BAD 0.39* 0.84* 0.47* 0.88* 0.43* 0.74* 1   
V2LIFT 0.28* 0.36* 0.21* 0.27* 0.33* 0.27* 0.31 1  
V2LIFTC 0.34* 0.44* 0.23* 0.30* 0.41* 0.32* 0.37 0.74* 1 
          
* <0.0001 
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Appendix Table 3. Back pain variables, Kaplan-Meier curves, and hazards ratios 
 
For all Tables: Multivariable I:  Age, education, married, and clinic location; Multivariable II:  
Model 1 + excellent health, smoker, obese, prevalent vertebral fracture at baseline, osteoarthritis, 
hip pain, fall in past year, hypertension, previous stroke, anxiety med, diabetes 
 
Appendix Table 3.1, All-cause mortality for BPFREQ  
(Primary definition of back pain for paper, using V1 and V2) 
 
(n=8915) 
 
Age Adjusted 
 
Model 1 
 
Model 2 
  
 
No 
back pain 
(n= 2112) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
 
 
Non- 
Persistent 
(n= 2059) 
 
 
1.04 
(0.96, 1.13) 
 
 
1.05 
(0.97, 1.13) 
 
 
1.01 
(0.93, 1.10) 
 
 
 
 
Infrequent 
(n=3897) 
 
 
1.04 
(0.97, 1.12) 
 
 
1.05 
(0.98, 1.12) 
 
 
0.95  
(0.88, 1.03) 
 
 
 
Frequent 
(n= 834) 
 
 
1.44 
(1.31, 1.59) 
 
 
1.41 
(1.28, 1.56) 
 
 
1.21  
(1.08, 1.35) 
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Appendix Table 3.2, All-cause mortality for V2BACK.  
At V2, any back pain in the last 12 months?  
      
 
 
(n=8915) 
 
 
Age Adjusted 
 
 
Model 1 
 
 
Model 2 
 
 
 
 
No 
(n=3457) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
 
 
Yes 
(n=5458) 
 
 
1.07 
(1.01, 1.13) 
 
 
1.06  
(1.01, 1.12) 
 
 
0.98  
(0.92, 1.05) 
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Appendix Table 3.2, All-cause mortality for V2LIM 
At V2, How often does your back pain bother you? 
 
(n=8915) 
Age Adjusted  
Model 1 
 
Model 2 
 
Never 
(n=3468) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
Rarely 
(n=878) 
 
0.89 
(0.80, 0.98) 
 
0.90 
(0.81, 0.99) 
 
0.93 
(0.84, 1.03) 
 
Some of time 
(n=3145) 
 
1.02 
(0.96, 1.08) 
 
1.02 
(0.96, 1.08) 
 
0.95 
(0.89, 1.02) 
 
Most of time 
(n=1052) 
 
1.27 
(1.17, 1.39) 
 
1.24 
(1.14, 1.35) 
 
1.10 
(0.99, 1.21) 
 
Constantly 
(n=372) 
 
1.58 
(1.40, 1.80) 
 
1.55 
(1.37, 1.77) 
 
1.35 
(1.18, 1.56) 
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Appendix Table 3.4, All-cause mortality for V2LIM 
At V2, do you limit activities due to back pain?  
     
 
 
(n=8885) 
 
Age 
Adjusted 
 
 
Model 1 
 
 
Model 2 
 
 
No 
(n=7552) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
 
Yes 
(n=1333) 
 
 
1.23  
(1.15, 1.32) 
 
 
1.23  
(1.15, 1.32) 
 
 
1.08  
(0.995, 1.17) 
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Appendix Table 3.5, All-cause mortality for V2TOTPART 
At V2, which areas of back bother you? (lower, mid, upper) (0, 1, 2, or 3 regions) 
     
 
(n=8913) 
Age 
Adjusted 
 
Model 1 
 
Model 2 
 
 
No  
Back Pain 
(n=3457) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
1 Region 
(n=2027) 
 
1.04  
(0.98, 1.11) 
 
1.05  
(0.99, 1.11) 
 
0.98  
(0.92, 1.05) 
 
2 Regions 
(n=1183) 
 
1.12  
(1.03, 1.21) 
 
1.09  
(1.01, 1.19) 
 
0.98  
(0.89, 1.07) 
 
3 Regions 
(n=270) 
 
1.22 
(1.05, 1.43) 
 
1.19  
(1.02, 1.39) 
 
0.97  
(0.82, 1.15) 
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Appendix Table 3.6, All-cause mortality for V2BAD 
At V2, what is the severity of your back pain? 
     
 
 
(n=8914) 
 
 
Age Adjusted 
 
 
Model 1 
 
 
Model 2 
 
 
No 
back pain 
(n=3457) 
 
 
Ref 
 
 
Ref 
 
 
Ref 
 
Mild 
(n=1490) 
 
0.95 
(0.87, 1.02) 
 
0.96  
(0.88, 1.04) 
 
0.95 
(0.88, 1.04) 
 
Moderate 
(n=3133) 
 
1.07 
(1.01, 1.14) 
 
1.06 
(1.00, 1.13) 
 
0.98 
(0.91, 1.05) 
 
Severe 
(n=834) 
 
1.31 
(1.20, 1.44) 
 
1.29 
(1.18, 1.42) 
 
1.10 
(0.99, 1.22) 
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Appendix Table 3.7, All-cause mortality for V2LIFT 
At V2, Any Difficulty lifting 10 lb. object? 
    
 
 
(n=8915) 
 
Age  
Adjusted 
 
 
Model 1 
 
 
Model 2 
 
No 
(n=6225) 
 
Ref 
 
Ref 
 
Ref 
 
Yes 
(n=2211) 
 
1.36 
(1.28, 1.44) 
 
1.35 
(1.27, 1.43) 
 
1.18 
(1.10, 1.26) 
 
Don’t do it 
(n=479) 
 
1.40 
(1.26, 1.57) 
 
1.44 
(1.29, 1.61) 
 
1.30 
(1.15, 1.46) 
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Appendix Table 3.8, All-cause mortality for V2LIFTC 
At V2, Any Difficulty lifting a 10lb. object, due to back pain? 
 
 
(n=8884) 
 
Age 
Adjusted 
 
 
Model 1 
 
 
Model 2 
 
 
None 
(n=6618) 
 
Ref 
 
Ref 
 
Ref 
 
Some 
(n=1610) 
 
1.20 
(1.12, 1.28) 
 
1.18 
(1.11, 1.27) 
 
1.09 
(1.01, 1.18) 
 
Much 
(n=312) 
 
1.76 
(1.54, 2.01) 
 
1.76 
(1.54, 2.01) 
 
1.49 
(1.28, 1.72) 
 
Unable 
(n=344) 
 
1.52 
(1.33, 1.72) 
 
1.51 
(1.33, 1.72) 
 
1.27 
(1.10, 1.46) 
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Appendix Table 4. Comparison of baseline sample characteristics for full analytic sample 
(n=8915), complete case sample (n=8321), and mediation for IADLs (n=7936), chair stand 
(n=6797), and gait speed (n= 6913).   
 
 
Analytic 
Sample 
 
Complete  
Case 
 
IADL 
Mediation 
 
Chair Stand 
Mediation 
 
Gait Speed 
Mediation 
 n=8915 n=8321 n=7936 n=6797 n= 6913 
 
Socio-demographic       
  Age at V2, y, mean (SD) 73.5 (5.1) 73.5 (5.0) 73.3 (5.0) 73.0 (4.8) 73.1 (4.8) 
  Education at V1, > 12 yrs, % 3373 (37.9) 3172 (38.1) 3038 (38.3) 2687 (39.5) 2718 (39.3) 
  Married at V1, % 4415 (49.5) 4173 (50.2) 4024 (50.7) 3492 (51.4) 3536 (51.2) 
  Lives alone at V1, yes, % 3692 (41.4) 3403 (40.9) 3218 (40.6) 2721 (40.0) 2779 (40.2) 
  Recruitment site at V1      
     Clinic A, % 2304 (25.8) 2125 (25.5) 2049 (25.8) 1845 (27.1) 1884 (27.3) 
     Clinic B, % 2246 (25.2) 2103 (25.3) 1988 (25.1) 1655 (24.4) 1690 (24.5) 
     Clinic C, % 2073 (23.2) 1963 (23.6) 1839 (23.2) 1550 (22.8) 1566 (22.7) 
     Clinic D, % 2292 (25.7) 2130 (25.6) 2060 (26.0) 1747 (25.7) 1773 (25.7) 
 
Health-related characteristics      
  General health at V1, excellent, % 2822 (31.7) 2665 (32.0) 2583 (32.6) 2302 (33.9) 2328 (33.7) 
  Current smoker at V2, % 709 (8.0) 658 (7.9) 611 (7.7) 489 (7.2) 498 (7.2) 
  BMI at V1, kg/m2, mean (SD) 26.2 (4.4) 26.2 (4.4) 26.2 (4.4) 26.1 (4.4) 26.2 (4.4) 
  Obese at V1, BMI >30.0, % 1745 (19.7) 1641 (19.7) 1566 (19.7) 1288 (19.0) 1330 (19.2) 
  Exercise (V1), 1 day / week, %* 6877 (77.2) 6469 (77.8) 6205 (78.2) 5423 (79.8) 5502 (79.6) 
 
Comorbid conditions      
  Prevalent vertebral fracture at V1, % 1732 (19.7) 1633 (19.6) 1543 (19.4) 1300 (19.1) 1330 (19.2) 
  Arthritis at V1, % 5519 (63.1) 5229 (62.8) 4976 (62.7) 4211 (62.0) 4307 (62.3) 
  Hip pain at V2, % 2741 (30.9) 2559 (30.8) 2445 (30.8) 2061 (30.3) 2112 (30.6) 
  Fall in last year at V2, %  2656 (29.9) 2457 (29.5) 2319 (29.2) 2012 (29.6) 2056 (29.7) 
  Hospitalized in last year at V2, % 1339 (15.1) 1235 (14.8) 1130 (14.2) 893 (13.1) 925 (13.4) 
  Depression, GDS > 6 at V2, %** 340 (4.5) 313 (4.5) 285 (4.2) 225 (3.7) 239 (3.8) 
  Hypertension calculated at V1, % 3407 (38.2) 3143 (37.8) 2962 (37.3) 2468 (36.3) 2523 (36.5) 
  Previous stroke at V2, % 270 (3.0) 247 (3.0) 225 (2.8) 163 (2.4) 170 (2.5) 
  Diabetes at V1, % 610 (6.9) 557 (6.7) 521 (6.6) 414 (6.1) 431 (6.2) 
  Breast cancer at V1, % 453 (5.1) 429 (5.2) 406 (5.1) 340 (5.0) 346 (5.0) 
  Breast surgery at V2, % 2259 (25.4) 2136 (25.7) 2044(25.8) 1759 (25.9) 1790 (25.9) 
 
Medication Utilization      
  Advil use in past yr (v2), >1 /wk, % 2434 (27.4) 2257 (27.2) 2139 (27.0) 1805 (26.6) 1855 (26.9) 
  Aspirin use in past yr (V2), >1 /wk, % 3470 (39.0) 3230 (38.9) 3077 (38.8) 2614 (38.5) 2656 (38.5) 
  Tylenol use in past yr (V2), >1 /wk, % 2112 (23.8) 1961 (23.6) 1849 (23.3) 1525 (22.5) 1572 (22.8) 
  Anxiety medication use (V2), any, %  1118 (13.4) 1115 (13.4) 1054 (13.3) 860 (12.7) 887 (12.8) 
Deaths after 8 years of follow-up, % 1862 (20.9) 1676 (20.1) 1407 (17.7) 1049 (15.4) 1089 (15.8) 
Deaths after 16 years of follow-up, % 4975 (55.8) 4590 (55.2) 4290 (54.1) 3535 (52.0) 3621 (52.4) 
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